Effect of nonsteroidal antiinflammatory drugs on plasma protein-thyroxine interaction.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D000983:Antipyrine / Q000494:pharmacology; D001241:Aspirin / Q000494:pharmacology; D001463:Barbiturates / Q000494:pharmacology; D001665:Binding Sites / Q000187:drug effects; D001798:Blood Proteins / Q000378:metabolism*; D003510:Cyclohexanes / Q000494:pharmacology; D005243:Feces / Q000032:analysis; D005439:Flufenamic Acid / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D007455:Iodine / Q000097:blood; D007457:Iodine Radioisotopes; D008297:Male; D008528:Mefenamic Acid / Q000494:pharmacology; D008698:Mesylates / Q000494:pharmacology; D009132:Muscles / Q000378:metabolism; D010113:Oxyphenbutazone / Q000494:pharmacology; D010648:Phenylacetates / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D011485:Protein Binding; D051381:Rats; D012116:Resins, Plant / Q000378:metabolism; D012980:Sodium Salicylate / Q000494:pharmacology; D013961:Thyroid Gland / Q000502:physiology; D013965:Thyroidectomy; D013974:Thyroxine / Q000378:metabolism*
D000893:Anti-Inflammatory Agents; D001463:Barbiturates; D001798:Blood Proteins; D003510:Cyclohexanes; D007457:Iodine Radioisotopes; D008698:Mesylates; D010648:Phenylacetates; D012116:Resins, Plant; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D007455:Iodine; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D013974:Thyroxine; D001241:Aspirin; D000983:Antipyrine; D012980:Sodium Salicylate; D007213:Indomethacin